Form 4: Esquire Financial Holdings Director Anthony Coelho Reports Share Transactions
SEC Form 4 Filing
Director Anthony Coelho of Esquire Financial Holdings reported the acquisition and disposal of common stock, as well as holdings in stock options, on December 24, 2024.
Summary
- Anthony Coelho, a director at Esquire Financial Holdings, reported transactions involving the company's common stock and stock options on December 24, 2024.
- He disposed of 1,167 shares of common stock and acquired 1,167 shares of common stock, both at a price of $0.
- Following these transactions, Mr. Coelho directly owns 28,039 shares of common stock and indirectly owns 12,910 shares through a trust and 36,000 shares through an IRA.
- Mr. Coelho also holds 22,231 stock options exercisable at $12.50, which were granted on September 1, 2016, and expire on September 1, 2024, and 20,000 stock options exercisable at $12.50, which were granted on September 1, 2017, and expire on September 1, 2026.
- The reported transactions include restricted stock that vests in annual installments over several years.
Sentiment
Score: 5
Explanation: The document is a neutral report of transactions, with no indication of positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which is a common practice for publicly traded companies. It provides transparency into the trading activities of company directors.
Comparison to Industry Standards
- Form 4 filings are standard practice for all publicly traded companies in the US, ensuring transparency of insider trading.
- The reported transactions are typical for directors who receive stock options and restricted stock as part of their compensation.
- The vesting schedules for restricted stock are also common, aligning director interests with long-term company performance.
Stakeholder Impact
- The filing provides transparency to shareholders regarding director transactions.
- The transactions do not appear to have any immediate impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 09/01/2016 | Grant date of 22,231 stock options exercisable at $12.50, expiring on 09/01/2024. |
| 09/01/2017 | Grant date of 20,000 stock options exercisable at $12.50, expiring on 09/01/2026. |
| 12/19/2023 | Commencement date for vesting of some restricted stock in three equal annual installments. |
| 12/24/2024 | Date of reported transactions involving common stock and stock options. |
| 12/16/2024 | Commencement date for vesting of some restricted stock in three equal annual installments. |
| 12/09/2025 | Commencement date for vesting of some restricted stock in three equal annual installments. |
| 12/19/2026 | Commencement date for vesting of some restricted stock in three equal annual installments. |
| 12/03/2027 | Commencement date for vesting of some restricted stock in three equal annual installments. |
| 12/15/2027 | Commencement date for vesting of some restricted stock in three equal annual installments. |
Keywords
Form 4, Beneficial Ownership, Director Transactions, Stock Options, Common Stock, Esquire Financial Holdings, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.